- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
AHR
NYSE
Week ended 31 Jul 2026
Weekly Investor Report
American Healthcare REIT, Inc. · Real Estate · Reit - Healthcare Facilities
Latest close
55.60 USD
-3.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 10.8% above the Trend Line and sits at 84.7% of its 52-week range. The latest completed week returned -3.2%, after a 1.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 37/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.
Setup score
64
out of 100
Latest Close
55.60 USD
31 Jul 2026
1W Return
-3.2%
latest completed week
4W Return
1.0%
short-term follow-through
12W Return
8.0%
quarterly tape
Trend Breadth
92.3%
48 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- 16 reversal markers appear in the recent smart-money tape.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.2%
Latest completed week; four-week move 1.0%.
Indicator stack
68/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 59.26%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
37/100 conviction; expected move 6.4%.
News sentiment
57/100
55 relevant articles in the latest sentiment read.
Event risk
5d
Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 10.8% above the Trend Line and sits at 84.7% of its 52-week range. The latest completed week returned -3.2%, after a 1.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6412-week average 0.55
12-week confirmation
Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.64Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1616 reversal markers
No recent accumulation markers. 16 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.0% over four weeks, 8.0% over 12 weeks, and 45.3% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year48
Trend breadth92.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.88Latest activity-pressure read.
Pressure change472.5%Four-week change in activity pressure.
Leadership7.30Latest relative-leadership reading.
RS change-12.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 97%
Model confidence 93%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength11/100Blend of value, momentum, and quality. Underlying universe rank 90; rank 1 is best.
Value4/100Relative valuation strength. Underlying universe rank 97; rank 1 is best.
Quality21/100Profitability and accounting quality. Underlying universe rank 80; rank 1 is best.
Momentum86/100Medium-term price momentum. Underlying universe rank 15; rank 1 is best.
Growth94/100Revenue and earnings growth. Underlying universe rank 7; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 110.3x Price divided by trailing earnings.
- Price / sales
- 4.7x Market value relative to trailing revenue.
- EV / EBITDA
- 34.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 9.6% Gross profit retained from each unit of revenue.
- Operating margin
- 5.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 21.3% Free cash flow generated from revenue.
- Return on invested capital
- 2.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 12.2% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 50.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.7% Cash dividends relative to market value.
- Buyback yield
- -11.7% Net share repurchases relative to market value.
- Shareholder yield
- -10.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.9x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
AHR shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.42, expected move of 6.4%, and Sharemaestro trend signal active.
Conviction37/100
Expected move6.4%
Put/call volume0.42
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 55 relevant articles.
20 positive · 35 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move6.4%Nearest-chain priced movement where available.
52-week drawdown-5.3%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher15 of 2611 weeks finished lower.
Best week+9.6%Week of 26 Jun.
Worst week-7.8%Week of 20 Mar.
Latest week-3.2%Week of 31 Jul.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses9
Sharp losses2
Recent vol4.5%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -2.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Real Estate
4-week rank42 / 100
Group average-0.5%
Trend breadth67.0%
Trend67.0%active weekly trend signals
MD79.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Reit - Healthcare Facilities
4-week rank6 / 15
Group average0.0%
Trend breadth86.7%
Trend86.7%active weekly trend signals
MD86.7%positive activity pressure
RS80.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape67/100
Trend, activity pressure, participation, and risk combine to a 67/100 tape read.
Indicator analysis45/100Latest 12-week confirmation: trend 8/12, activity pressure 4/12, relative leadership 6/12.
Activity pressure 0.64; 16 reversal markers Next-Week ExpectancyPositive 59.26%Next-week expectancy is positive with a 59.26% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors27/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 87; Small Cap Core rank 99 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options53/100AHR shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.42, expected move of 6.4%, and Sharemaestro trend signal active.
Bullish · Call-side pressure · Expected move 6.4% Sentiment57/100Weighted news tone is neutral across 55 relevant articles.
American Healthcare REIT, Inc. (AHR) Q3 2024 Earnings Report - Results, Call & Slides Insiders50/100No recent insider transaction evidence is stored.
Earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 55.60 USD | -3.2% | 50.16 USD | 33.14 USD | 0.88 | 7.30 | 11.6M | On |
| 24 Jul 2026 | 57.44 USD | 0.5% | 49.87 USD | 32.96 USD | 0.93 | 12.45 | 10.6M | On |
| 17 Jul 2026 | 57.16 USD | 6.7% | 49.54 USD | 32.77 USD | 0.72 | 11.85 | 11.1M | On |
| 10 Jul 2026 | 53.57 USD | -2.7% | 49.22 USD | 32.58 USD | 0.21 | 3.70 | 16.1M | On |
| 3 Jul 2026 | 55.04 USD | 8.4% | 48.99 USD | 32.41 USD | -0.24 | 8.38 | 17.8M | On |
| 26 Jun 2026 | 50.76 USD | 9.6% | 48.81 USD | 32.23 USD | -0.80 | 2.54 | 42.2M | Off |
| 19 Jun 2026 | 46.30 USD | -0.6% | 48.80 USD | 32.08 USD | -1.14 | -8.38 | 15.0M | Off |
| 12 Jun 2026 | 46.59 USD | -1.4% | 48.83 USD | 31.97 USD | -1.12 | -6.89 | 13.5M | Off |
| 5 Jun 2026 | 47.25 USD | -2.9% | 48.88 USD | 31.85 USD | -1.07 | -4.91 | 9.6M | Off |
| 29 May 2026 | 48.66 USD | -2.6% | 48.93 USD | 31.72 USD | -0.75 | -4.38 | 12.1M | On |
| 22 May 2026 | 49.95 USD | 1.7% | 48.80 USD | 31.58 USD | -0.59 | -0.25 | 16.7M | On |
| 15 May 2026 | 49.11 USD | -4.6% | 48.60 USD | 31.43 USD | -0.54 | -0.82 | 13.0M | On |
| 8 May 2026 | 51.46 USD | 3.1% | 48.39 USD | 31.28 USD | -0.52 | 4.36 | 12.2M | On |
| 1 May 2026 | 49.91 USD | -0.4% | 48.02 USD | 31.10 USD | -0.71 | 3.85 | 8.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.